DJO Global Showcases New Bracing and Supports Products at American Academy of Orthopedic Surgeons Meeting

Posted by: Doctor Medical  :  Category: Health News

If the problem continues, please contact WebSupport@BusinessWire.com. Please include the full URL you were attempting to reach as well as your contact information.

If you are a client trying to submit a news release, please contact your local Business Wire bureau or call:

  • US: +1.888.381.WIRE(9473)
  • Australia: +61 (0) 2.9699.2219
  • Belgium: +32 (0) 2.741.2455
  • Canada: +1.416.593.0208
  • France: +33 (0) 1.56.88.29.40
  • Germany: +49 (0) 69.915066.0
  • Japan: +81 (0) 3.3239.0755
  • UK: +44 (0) 20.7626.1982
  • All Countries: +1 415.986.4422

Return to your Business Wire homepage

Article source: Read More

Zix Corporation Offers Superior TLS Support with Introduction of ZixGateway 4.3

Posted by: Doctor Medical  :  Category: Health News

DALLAS–(BUSINESS WIRE)–Zix
Corporation
(ZixCorp), (NASDAQ: ZIXI), the leader in email
encryption services, has integrated transport layer security (TLS)
delivery in the new release of ZixGateway®.
Ideal for compliance and security officers, TLS email through ZixGateway
reduces administration, enhances transparent delivery, provides
guaranteed encrypted replies and enables reporting capabilities that do
not exist with any other TLS email solution.

“Now, not
only do we provide customers with a superior option, we encrypt replies
and deliver reporting that is critical to security and compliance
professionals.”

ZixGateway 4.3, a policy-based email encryption service, integrates TLS
delivery directly into the policy administration console, enabling
simple and easy TLS management. By integrating TLS in the policy
console, compliance and security officers have access to reports that
log the delivery/ mechanism of every secure email message. As a result
of this unique feature, ZixGateway 4.3 gives compliance and security
officers the control and visibility they need.

Other unique features offered by ZixGateway 4.3 with TLS email support
include:

  • Secure, bidirectional transparency – ZixCorp’s Best Method of
    Delivery
    SM chooses the most secure and
    transparent delivery method available for each message. TLS, as
    generally used in the market today, has a major flaw; it cannot
    guarantee the encryption of replies. ZixCorp’s S/MIME solution
    provides bidirectional transparency, guaranteeing encrypted replies.
    If S/MIME is not available, TLS can be configured as an alternative
    transparent delivery method.
  • Simplified management of mandatory TLS – By making TLS a part of the
    sender’s email encryption policies, TLS can be added as a delivery
    method with the click of a button. By replacing the need for
    individual TLS configurations, ZixGateway allows organizations to
    avoid the cost and time typically associated with managing each TLS
    connection.
  • Increased delivery control – TLS used to be all or nothing. By making
    TLS a part of the ZixGateway policies, TLS can be used where
    appropriate.
  • Branding of recipient messages – Every message sent via TLS can be
    marked to indicate that it was sent securely, providing confidence to
    your recipients that the email and its sensitive content were
    delivered securely.

Secure, bidirectional transparency, simplified management of mandatory
TLS, increased control through policy-management and security branding
are features not available in competing TLS email solutions.

“We place significant emphasis on the importance of convenient security.
Mandatory TLS is not convenient, and opportunistic TLS is not safe. We
resolved these issues and preserved the strengths of both methods in our
latest release of ZixGateway,” said Rick
Spurr
, ZixCorp’s Chairman and Chief Executive Officer. “Now, not
only do we provide customers with a superior option, we encrypt replies
and deliver reporting that is critical to security and compliance
professionals.”

Industry-standard TLS email has two delivery methods – mandatory and
opportunistic. Mandatory TLS ensures a secure message by establishing a
connection between two email servers, which requires investment of time
and specialized staff to set-up and maintain. Opportunistic TLS requires
minimal administration time or costs and automatically sends a message
securely if a TLS connection exists. When a TLS connection does not
exist, however, the message may be automatically delivered without any
protection, and the security of replies is not assured. Neither of these
industry-standard methods provides reporting capabilities that security
and compliance professionals need. ZixGateway 4.3 solves all of these
problems.

ZixGateway 4.3 with enhanced TLS support is now commercially available.
For additional information, please visit ZixCorp’s booth – no. 550 – at
the RSA
Conference
on February 27 – March 1, 2012, or contact
866-257-4949.

About Zix Corporation

Zix Corporation provides the only email encryption services designed
with your most important relationships in mind. The most influential
companies and government organizations use the proven ZixCorp®
Email Encryption Services, including WellPoint, the SEC and more than
1,200 hospitals and 1,600 financial institutions. ZixCorp Email
Encryption Services are powered by ZixDirectory®, the
largest email encryption community in the world. The tens of millions of ZixDirectory
members can feel secure knowing their most important relationships are
protected. For more information, visit www.zixcorp.com.

Article source: Read More

Consumer groups want tougher probe of engineered salmon

Posted by: Doctor Medical  :  Category: Health News


WASHINGTON |
Tue Feb 7, 2012 9:49pm EST

WASHINGTON (Reuters) – Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

The fish at issue, AquaBounty Technologies’ AquAdvantage salmon, is currently classified as a new animal drug for the purposes of FDA review.

The FDA considers any genetically altered animal a new animal drug for approval purposes. The petition calls for the salmon to be classified as a food additive instead, which would require a more rigorous FDA review.

AquaBounty is seeking U.S. approval to market its engineered Atlantic salmon, which contains a gene from another fish species, the Chinook salmon, to help it grow twice as fast as normal.

The consumer groups’ petition says the way these salmon are created substantially alters their composition and nutritional value, and so they should be treated as a food additive. Under this standard, they said, the company’s data would have to overwhelmingly prove AquAdvantage salmon are safe to eat.

The consumer groups – Food Water Watch, Consumers Union, and the Center for Food Safety – said in a statement the “new animal drug” designation is insufficient to protect public health. The review process for food additives offers greater protection, they said.

AquaBounty had no comment on the petition.

The FDA did not comment specifically on the petition, but confirmed that the company’s application for FDA approval for AquAdvantage salmon is under review, and that genetically engineered animals are evaluated under the new animal drug provisions of U.S. law.

AquaBounty has said in the past that it sees these genetically modified salmon as a potential solution to environmental concerns associated with salmon aquaculture, and discounted fears they might accidentally escape into the wild and affect other fish.

However, Food Water Watch Executive Director Wenonah Hauter said the company’s own study showed that genetically engineered salmon may contain increased levels of a hormone linked to breast, colon, prostate and lung cancer.

The petitioners said a proper review would require genetically engineered salmon to go through comprehensive toxicological studies to ensure the fish are safe to consume and properly labeled.

If approved, AquAdvantage would be the first genetically altered animal for human consumption in the United States.

Genetically modified vegetables such as corn have long been on the U.S. market, and the FDA allows modified animals as pets or to help produce biologic medicines.

There is no timeline for an FDA decision. As a matter of policy, the FDA does not comment on citizen petitions.

(Reporting By Deborah Zabarenko, Environment Correspondent; Editing by Todd Eastham)

This story updates clarifies the sixth paragraph reference to new animal drug

Article source: Read More

White House defends contraception rules as criticism mounts

Posted by: Doctor Medical  :  Category: Health News


WASHINGTON |
Tue Feb 7, 2012 8:50pm EST

WASHINGTON (Reuters) – The Obama administration is willing to work with Catholic universities, hospitals and other church-affiliated employers to implement a new policy that requires health insurers to offer birth control coverage, a top adviser to the president’s re-election campaign said on Tuesday.

David Axelrod, a senior campaign adviser to President Barack Obama, said the administration had heard the Roman Catholic Church’s concerns and never intended to “abridge anyone’s religious freedom.”

But he gave no sign that the administration would reverse course under intensifying pressure from church leaders and political heat from Republican presidential candidates.

“This is an important issue. It’s important for millions of women across this country. We want to resolve it in an appropriate way, and we’re going to do that,” Axelrod said in remarks on MSNBC’s “Morning Joe” program.

White House spokesman Jay Carney also sought to diffuse criticism from church leaders, telling reporters later on Tuesday the administration would work with religious organizations “to see if the implementation of the policy can be done in a way that allays some of those concerns.”

U.S. Catholic bishops have slammed the Obama administration for a regulation finalized on January 20 that would require health insurance to include birth control and other preventative health services for women. The leaders contend the policy infringes on religious liberty because the church does not condone birth control of any kind.

Over the weekend, Catholic clergy across the country called for congregations to pressure Obama to back down.

“To force American citizens to choose between violating their consciences and forgoing their healthcare is literally unconscionable,” said Cardinal-designate Timothy Dolan, archbishop of New York and president of the U.S. Conference of Catholic Bishops, in a statement last month.

Jim Towey, president of Ave Maria University in Florida, who also served in the administration of President George W. Bush, said on Tuesday he would fight the provision using “all lawful means at our disposal.”

“Our non-Catholic employees and students understand fully that the University must adhere to Catholic teaching and they do not expect us to provide such services,” he said in a statement.

REPUBLICANS SEE ASSAULT

The controversy centers on a provision in the 2010 healthcare bill which requires health insurance to cover basic preventative services for women. An advisory group, the Institute of Medicine, had recommended covering a fuller range of contraceptive services to help prevent unwanted pregnancies.

U.S. Health and Human Services Secretary Kathleen Sebelius adopted the institute’s recommendation but included an exemption for churches, although not related religious organizations such as hospitals.

Twenty-eight U.S. states already require health insurers to cover contraception.

The issue quickly took on political dimensions, with Republican presidential contenders criticizing the administration for violating religious liberties. Obama is seeking re-election in what many see as a referendum on his performance during the last three years.

Republican presidential frontrunner Mitt Romney, in Colorado on Tuesday, called the requirement an “assault on religion.”

Republican rival Rick Santorum, who is Catholic, called the White House’s comments “ridiculous” while speaking in Colorado on Monday. Rival Newt Gingrich, also a Catholic, has also declared the policy a war on religious freedom.

Florida Senator Marco Rubio, whose name has surfaced as a possible Republican vice presidential candidate, has introduced a bill to further expand the exemption for religious employers.

On Capitol Hill, the top Republican on the Senate Judiciary Committee, Senator Chuck Grassley, urged the Obama administration to rescind the provision.

“As currently written, this mandate will result in litigation that could be avoided if HHS issued a regulation that showed greater respect for religious freedom,” Grassley said in a letter to Sebelius.

In remarks on the Senate Floor, Senator Barbara Mikulski, a Maryland Democrat, said the debate was off in the wrong direction. “For the first time in a long time, our nation is talking about women’s health, … but unfortunately, too much of it isn’t really about women’s health. It is politics disguised as women’s health,” Mikulski said.

ALLAYING CONCERNS

Just how religious-based organizations could implement the rule to meet the Obama administration’s criteria while still holding fast to their core beliefs remains to be seen.

Carney offered no details but said the White House would discuss possible avenues over the next 18 months.

Jennifer Duffy, senior political analyst for The Cook Political Report, said neither side was likely to back down in the run-up to the election.

“I don’t think the bishops have any intention of letting this fade and, especially if their position is intractable, then it’s a fight,” she said. “It becomes a staring contest.”

Emergency contraception, also known as the “morning after pill” and seen by many conservatives as akin to abortion, for the most part would not fall under the rule since it is already available without a prescription to those 17 and older.

Women’s rights groups and other contraception supporters, who were disappointed last year when the Obama administration rejected a push to make emergency contraception more widely available, had feared Obama might widen the exemption.

Susan Wood, a health professor at George Washington University’s Jacobs Institute of Women’s Health who backs birth control, said religious groups should have no more control over what employees do with their insurance than with their salaries.

“This is an employee benefit issue. This is not the Catholic

Church having to provide a service directly. No Catholic hospital is going to be required to write a prescription or provide a pack of pills.”

Two polls released by Planned Parenthood, which provides birth control and reproductive services, showed the majority of voters, including Catholics, support contraceptive coverage.

(Reporting By Susan Heavey; additional reporting by Steve Holland in Colorado, Laura MacInnis in Washington and Greg McCune in Chicago; Editing by Marilyn W. Thompson, Eric Beech and Todd Eastham)

Article source: Read More

InVivoLink and American Joint Replacement Registry Collaborate for Patient Safety

Posted by: Doctor Medical  :  Category: Health News

NASHVILLE, Tenn.–(BUSINESS WIRE)–InVivoLink
and the American
Joint Replacement Registry
(AJRR) have announced the two
organizations will collaborate on technology that automates the feed of
orthopedic implant data to the AJRR’s registry platform. The direct link
between InVivoLink’s registry data acquisition tools and the AJRR
facilitates a nationwide orthopedic implant registry project designed to
monitor medical device performance and improve patient outcomes.

“The AJRR’s new collaboration with InVivoLink is a valuable one, because
it strengthens the AJRR’s mission of improving patient safety and
increasing quality of care while removing costs”

“The AJRR’s new collaboration with InVivoLink is a valuable one, because
it strengthens the AJRR’s mission of improving patient safety and
increasing quality of care while removing costs,” said David Lewallen,
M.D., chair of the AJRR.

Projected growth in total joint replacement procedures coupled with
their rising costs present significant challenges for providers and
payers. The combined initiative by InVivoLink and the AJRR addresses
these issues by providing data to support evidence-based medicine,
identifying patients at risk for poor outcomes, improving the tracking
of complication rates, and enhancing management of device recalls.

InVivoLink is a web-based platform that automates implant registry data
capture throughout the continuum of care. InVivoLink’s innovative data
collection process
simplifies providers’ participation in local and
national registry initiatives by using automated processes and
delivering high-quality data.

“As a former total joint replacement surgeon at The New Mexico Center
for Joint Replacement Surgery and one who has maintained a comprehensive
research database for all total hip and knee replacements since 1982, I
understand the importance of collecting accurate data associated with
the patient and his or her implants. Now that I’m in an administrative
role with a hospital, I value the efficient and effective mode of data
collection through InVivoLink’s process. Having their assistance in
gathering the right metrics for not only a national joint registry but
also monitoring fiscal performance has been a tremendous success,” said
Richard E. White, Jr., M.D., who practiced in Albuquerque for 30 years
and currently is an administrative consultant for clinical and fiscal
development in total joint replacement for the three hospitals of
Lovelace Health System in Albuquerque.

“InVivoLink is dedicated to supporting the AJRR’s initiative by making
it easy to participate in the national registry while providing an
overarching value proposition to the hospital,” said Ryan
Wells, InVivoLink CEO
. “What we are doing is remarkable because it
is a system that supports evidence-based medicine while paying for
itself through operational value to the hospital.”

About the American Joint Replacement Registry (AJRR)

The AJRR is a multi-stakeholder, independent, not-for-profit
organization with diverse national constituents and the goal of
optimizing patient outcomes through collection of data on all primary
and revision total joint replacement procedures in the U.S. The mission
of the registry is to improve patient safety, increase quality of care
and reduce the cost of care. Learn more at http://orthodoc.aaos.org/ajrr/grp_index.cfm.

About InVivoLink

InVivoLink (IVL) collects, monitors and disseminates medical device data
via its implant registry technology. IVL works to
improve clinical outcomes, elevate the patient experience, and remove
waste throughout the continuum of care by enabling providers to more
effectively engage patients and partners. For more information, visit www.invivolink.com.

Article source: Read More